Interestingly, previous studies showed evidence that the brain renin–angiotensin system (RAS) and the Rho kinase (ROCK) pathway modulate neuroinflammation and oxidative stress in PD, pointing to these systems as possible new targets for the treatment of LID [39,41,43,44,45,46,47,48]. The gene discussed is REN; the disease is Parkinson disease.